Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

Repros Therapeutics Inc. (MM) (RPRXD)

Repros Therapeutics Inc. (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RPRXD
DateTimeSourceHeadlineSymbolCompany
10/11/201017:27Edgar (US Regulatory)Current report filing (8-K)NASDAQ:RPRXDRepros Therapeutics Inc. (MM)
09/11/201018:29Business WireRepros® Therapeutics Reports Outcome of Type B Meeting with FDA Regarding Androxal® in the Treatment of Secondary HypogonadismNASDAQ:RPRXDRepros Therapeutics Inc. (MM)
01/11/201016:27Edgar (US Regulatory)Current report filing (8-K)NASDAQ:RPRXDRepros Therapeutics Inc. (MM)
29/10/201022:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RPRXDRepros Therapeutics Inc. (MM)
29/10/201022:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RPRXDRepros Therapeutics Inc. (MM)
29/10/201022:04Business WireRepros® Has Regained Compliance with Nasdaq Continued Listing RequirementsNASDAQ:RPRXDRepros Therapeutics Inc. (MM)
25/10/201018:05Edgar (US Regulatory)Current report filing (8-K)NASDAQ:RPRXDRepros Therapeutics Inc. (MM)
25/10/201015:36Business WireRepros® Therapeutics Begins Randomization of Subjects in Androxal® Type II Diabetes Phase II TrialNASDAQ:RPRXDRepros Therapeutics Inc. (MM)
15/10/201022:39Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RPRXDRepros Therapeutics Inc. (MM)
15/10/201015:53Edgar (US Regulatory)Current report filing (8-K)NASDAQ:RPRXDRepros Therapeutics Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:RPRXD